Frankfurt - Delayed Quote EUR

Quoin Pharmaceuticals Ltd. S (2EB0.F)

6.94
-0.14
(-1.98%)
At close: June 12 at 9:49:51 PM GMT+2
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
11,027.36
9,528.47
9,378.50
9,257.70
6,062.85
Operating Income
-11,027.36
-9,528.47
-9,378.50
-9,257.70
-6,062.85
Net Non Operating Interest Income Expense
565.85
558.49
694.61
-618.34
-1,365.41
Other Income Expense
14.14
7.50
-2.68
494.54
-14,034.33
Pretax Income
-10,447.37
-8,962.47
-8,686.57
-9,381.50
-21,462.59
Net Income Common Stockholders
-10,447.37
-8,962.47
-8,686.57
-9,446.76
-21,462.59
Diluted NI Available to Com Stockholders
-10,447.37
-8,962.47
-8,686.57
-9,446.76
-21,462.59
Basic EPS
-0.99
-1.91
-9.64
-46.81
-815.52
Diluted EPS
-0.99
-1.91
-9.64
-46.81
-815.52
Basic Average Shares
9,293.30
4,688.72
900.92
201.83
26.32
Diluted Average Shares
9,293.30
4,688.72
900.92
201.83
26.32
Total Expenses
11,027.36
9,528.47
9,378.50
9,257.70
6,062.85
Net Income from Continuing & Discontinued Operation
-10,447.37
-8,962.47
-8,686.57
-9,381.50
-21,462.59
Normalized Income
-10,461.51
-8,969.97
-8,683.89
-9,798.80
-21,462.59
Interest Income
565.85
558.49
694.61
95.75
0
Interest Expense
--
--
0
714.08
1,090.41
Net Interest Income
565.85
558.49
694.61
-618.34
-1,365.41
EBIT
-11,027.36
-9,528.47
-9,378.50
-8,667.42
-20,372.18
EBITDA
-10,927.36
-9,428.47
-9,274.80
-8,563.37
-20,268.14
Reconciled Depreciation
100
100
103.71
104.04
104.04
Net Income from Continuing Operation Net Minority Interest
-10,447.37
-8,962.47
-8,686.57
-9,381.50
-21,462.59
Total Unusual Items Excluding Goodwill
14.14
7.50
-2.68
417.31
0
Total Unusual Items
14.14
7.50
-2.68
417.31
0
Normalized EBITDA
-10,941.50
-9,435.97
-9,272.12
-8,980.68
-20,268.14
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/2/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade